(Q44477055)

3 December 2017

Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis (English)

1 reference

3 December 2017

0 references

1 reference

3

Barbara P Barna

1 reference

3 December 2017

8

Mary Jane Thomassen

1 reference

3 December 2017

Tracey L Bonfield

1

1 reference

3 December 2017

Carol F Farver

2

1 reference

3 December 2017

Anagha Malur

4

1 reference

3 December 2017

Susamma Abraham

5

1 reference

3 December 2017

Baisakhi Raychaudhuri

6

1 reference

3 December 2017

Mani S Kavuru

7

1 reference

3 December 2017

12 June 2003

1 reference

American Journal of Respiratory Cell and Molecular Biology

3 December 2017

1 reference

3 December 2017

29

1 reference

3 December 2017

6

1 reference

3 December 2017

677-682

1 reference

Prostaglandin and PPAR control of immune cell function

3 December 2017

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

PPARgamma in monocytes: less pain, any gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Pulmonary alveolar proteinosis: progress in the first 44 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Pulmonary surfactant in health and human lung diseases: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Emerging roles of PPARs in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

Cytokines as therapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2003-0148OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2003-0148OC

1 reference

3 December 2017

1 reference